Some structive-activity relationships for mitomycin C (NSC-26980) derivatives in the treatment of L1210 leukemia.
D000081:Acetamides / Q000627:therapeutic use; D000478:Alkylation; D000588:Amines / Q000627:therapeutic use; D000818:Animals; D001389:Azirines / Q000627:therapeutic use; D002219:Carbamates / Q000627:therapeutic use; D006900:Hydroxylation; D007939:Leukemia L1210 / Q000188:drug therapy* / Q000401:mortality; D051379:Mice; D008807:Mice, Inbred BALB C; D008811:Mice, Inbred DBA; D008937:Mitomycins / Q000008:administration & dosage / Q000627:therapeutic use*; D011160:Porfiromycin / Q000627:therapeutic use; D011379:Prognosis; D013329:Structure-Activity Relationship
D000081:Acetamides; D000588:Amines; D001389:Azirines; D002219:Carbamates; D008937:Mitomycins; D011160:Porfiromycin